Targeted therapy with a cytotoxic somatostatin analog, AN-238, inhibits growth of human experimental endometrial carcinomas expressing multidrug resistance protein MDR-1.
about
Loss of somatostatin receptor subtype 2 in prostate cancer is linked to an aggressive cancer phenotype, high tumor cell proliferation and predicts early metastatic and biochemical relapseThe GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets.Targeted chemotherapy using a cytotoxic somatostatin conjugate to inhibit tumor growth and metastasis in nude mice.Somatostatin and somatostatin receptors: implications for neoplastic growth and cancer biology.The dipeptide monoester prodrugs of floxuridine and gemcitabine-feasibility of orally administrable nucleoside analogs.Receptor-mediated tumor targeting based on peptide hormones.Valproic acid induces NET cell growth arrest and enhances tumor suppression of the receptor-targeted peptide-drug conjugate via activating somatostatin receptor type II.On the design principles of peptide-drug conjugates for targeted drug delivery to the malignant tumor site.
P2860
Q28540624-6C114E09-2129-4496-A1D0-BC4F37240C15Q34182483-9EAEE2BD-B43B-4E17-9CCE-3A3CAE5DE5A2Q35180952-31B766B4-72FE-437B-A5E6-E3AF1D23EFB2Q37579225-33A5DAA0-C8EE-42EB-8FB4-6185A15B09C5Q37617635-E2E1BD12-263B-4536-B5FA-A23B7E235114Q37641368-A18D8B5B-E648-4ED9-8A5A-F69B58F7F762Q38849324-734803A3-B962-4B0C-A400-2CDF9BC9D448Q55054276-66A478FE-A5AF-4899-896F-FEEE481CB898
P2860
Targeted therapy with a cytotoxic somatostatin analog, AN-238, inhibits growth of human experimental endometrial carcinomas expressing multidrug resistance protein MDR-1.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Targeted therapy with a cytoto ...... drug resistance protein MDR-1.
@en
type
label
Targeted therapy with a cytoto ...... drug resistance protein MDR-1.
@en
prefLabel
Targeted therapy with a cytoto ...... drug resistance protein MDR-1.
@en
P2093
P50
P356
P1433
P1476
Targeted therapy with a cytoto ...... idrug resistance protein MDR-1
@en
P2093
Attila Nagy
Gunhild Keller
P304
P356
10.1002/CNCR.21327
P407
P577
2005-09-01T00:00:00Z